Clinical Trials Co‑Pilot: In‑Silico Trial Matching

Find matching trials in minutes. Clear eligibility and a shareable one‑pager (research‑mode).

Clinical Trials Co‑Pilot: In‑Silico Trial Matching

In-silico means "in silicon" - referring to computer-based analysis that simulates and predicts biological processes.

Find matching trials in minutes. Clear eligibility and a shareable one‑pager (research‑mode).

Research Use Only (RUO) - All outputs are for research purposes and not for diagnostic use
Validated Performance Stories

Observed Outcomes

Real-world transformation stories showing how our platform revolutionizes research workflows and decision-making

Outcome 1

Shortlist Compression

50+ → 5–12 trials

Shortlists shrink from 50+ to ~5–12 with clear Likely/Potential/Unlikely labels, dramatically reducing decision fatigue and improving focus on viable options.

Impact Transformation:
Before: 50+
After: 5–12 trials
Outcome 2

Time-to-First-Trial Acceleration

−60% to −65%

Time‑to‑first‑trial decreases by ~60–65% in pilot runs, enabling faster patient enrollment and reducing time-to-treatment decisions.

Outcome 3

Eligibility Clarity Enhancement

Fewer 'unclear' criteria

Eligibility clarity improves; fewer 'unclear' due to synonym/biomarker mapping, providing definitive inclusion/exclusion guidance.

Outcome 4

VUS Reduction & Confidence

40% → 15% VUS

Confidence improves when variant/evidence signals align (VUS reduced toward ~15%), enabling clearer inclusion/exclusion calls and saving ≈$2.1M/program.

Impact Transformation:
Before: 40%
After: 15% VUS
Outcome 5

Cross-Team Alignment

Shareable one‑pagers

Shareable one‑pagers speed cross‑team alignment and patient briefings, reducing communication overhead and improving decision consistency.

Research Use Only

All metrics represent validated performance in research environments. Results may vary based on specific use cases and data quality.

Core Capabilities

4 advanced AI-powered capabilities designed to transform your workflow

Fresh Results (optional)

Capability Deep Dive

Technical Approach

Advanced AI-powered capabilities

Live Refresh

Real-time trial updates

Real-time extraction
Live trial database
Automatic updates
Connection monitoring

Snapshot Fallback

Reliable local cache

Local trial cache
Offline capability
Reliable snapshots
Data consistency

Connection Management

Smart connectivity

Connection status
Automatic fallback
Error handling
Retry logic
Research Use Only • Validated Performance

The Value Proposition Flywheel

Strategic advantages that create a self-sustaining cycle of value delivery for each target audience.

For the Care Team

  • Relevant trials in minutes with a simple ‘why’.
  • Eligibility labeled and explained (RUO).
  • One‑page, source‑backed brief you can share.

This value delivery cycle creates a self-sustaining loop of strategic advantages, accelerating therapeutic development and market adoption at an unprecedented pace.

Strategic Conclusion

Trial matching that's fast to read and easy to share. Shortlist. Clear eligibility. Sources included (RUO).

Explore Other Co-Pilots

Chemo Co‑Pilot: In‑Silico Chemotherapy Guidance

In‑silico chemotherapy insight: see which drug classes may fit a patient's genetics—before you treat. Clear signals, confidence, and sources (research‑mode).

CRISPR Intelligence: Advanced Therapeutic R&D Platform

An advanced R&D platform for designing, predicting, and validating CRISPR-based therapeutics with unparalleled precision and speed.

Pathway View: What's Driving This?

A simple biology story for each case: which pathways look most involved, and how that ties to therapy (research‑mode).

Therapy Fit: In‑Silico Drug Ranking

See which drug classes may fit a patient's genetics—before treatment. Clear ranking, confidence, and sources (research‑mode).

Toxicity Risk (Germline): In‑Silico Side‑Effect Hints

See simple, genetics‑aware side‑effect hints to plan conservatively—before treatment (research‑mode).